« Back to Record
Citation APA

Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Mineur, P., Le Roy, C., Saint-Georges, S., Varin-Blank, N., Cymbalista, F., Bron, D., & Lagneaux, L. (2012). AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica, 97(4), 608-615. doi:10.3324/haematol.2011.052779


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144367

Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Mineur, P., Le Roy, C., Saint-Georges, S., Varin-Blank, N., Cymbalista, F., Bron, D., & Lagneaux, L. (2012). AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica, 97(4), 608-615. doi:10.3324/haematol.2011.052779